Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Ireland set to restrict use of AstraZeneca vaccine -RTE

04/12/2021 | 09:35am EDT

DUBLIN, April 12 (Reuters) - Ireland's National Immunisation Advisory Committee is expected to recommend that AstraZeneca's COVID-19 vaccine be restricted for use for people over the age of 60, national broadcaster RTE reported on Monday.

The expert group met to discuss the issue on Monday and RTE said it was due to sign off on the issue shortly. A formal announcement is expected later, it added.

A European Medicines Agency (EMA) investigation of blood clots in the brain reported by some people given the AstraZeneca vaccine has prompted some European countries to change their recommendations on who should be given the vaccine. (Reporting by Padraic Halpin; editing by David Evans)


© Reuters 2021
All news about ASTRAZENECA PLC
05:40pCorrection to Impact of U.S. Support for Patent Waiver on Vaccine Makers Arti..
DJ
04:54pASTRAZENECA PHARMA INDIA  : Key EU countries rebuff Biden on sharing COVID vacci..
RE
04:16pAstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emerge..
DJ
04:04pAstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emerge..
DJ
03:48pMARKET CHATTER : WHO's Director General Calls for Countries to Support Waiving C..
MT
01:19pU.S. Support for Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Sh..
DJ
01:18pHow the U.S. locked up vaccine materials other nations urgently need
RE
12:54pWHO Endorses China's Covid-19 Vaccine Sinopharm -- 4th Update
DJ
12:26pASTRAZENECA  : WHO panel OKs emergency use of China's Sinopharm vaccine
AQ
11:51aSINOVAC BIOTECH  : WHO gives emergency approval to first Chinese COVID-19 vaccin..
RE
More news
Financials (USD)
Sales 2021 30 843 M - -
Net income 2021 4 575 M - -
Net Debt 2021 11 038 M - -
P/E ratio 2021 29,9x
Yield 2021 2,64%
Capitalization 142 B 142 B -
EV / Sales 2021 4,96x
EV / Sales 2022 4,35x
Nbr of Employees 76 100
Free-Float 95,8%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 130,07 $
Last Close Price 108,20 $
Spread / Highest target 53,4%
Spread / Average Target 20,2%
Spread / Lowest Target -12,1%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC5.61%139 932
JOHNSON & JOHNSON7.07%441 726
ROCHE HOLDING AG-3.06%284 771
PFIZER, INC.6.47%218 608
ABBVIE INC.8.03%204 861
MERCK & CO., INC.-4.14%196 943